Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity
正常人静脉注射免疫球蛋白(IVIg)通过F(ab')2介导的抗补体活性延缓超急性异种移植排斥反应。
期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1046/j.1365-2249.1997.4591358.x
Latremouille, C; Genevaz, D; Hu, M C; Schussler, O; Goussef, N; Mandet, C; Bruneval, P; Haeffner-Cavaillon, N; Carpentier, A; Glotz, D